IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)
August 19, 2021
August 19, 2021
August 19, 2021
July 27, 2021
July 7, 2021
June 8, 2021
February 25, 2021
February 10, 2021
December 16, 2020
December 10, 2020
January 9, 2025
Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmac...
January 8, 2025
Seasoned executive joins PrecisionLife to drive commercial strategy for new first-in-class precision medicine tests to predict and prevent complex, ch...
January 8, 2025
Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicin...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225